Tozaro is a biotech company leveraging molecular modelling and machine learning (ML) to design and develop stable and cost-effective polymers that bind to gene therapy vectors specifically & selectively. The Smart Polymer™ platform utilises >500 chemical groups to develop specific binding compounds, compared to traditional technologies using proteins and peptides, which use ca. 20 amino acids. Tozaro is able to mine a huge new chemical space using cost-effective Smart Polymers™
- Health
- Bedfordshire, United Kingdom
- £6m
- tozaro.com
- Update Information
More venture news
- 19 May 2026

NEX Health IntelligenceNEX Health Intelligence unlocks a £870k pre-seed round led by Brighteye Ventures for software that predicts the spread of infections in hospitals
Pre-seedHealth - 18 May 2026

Prema CognitionPrema Cognition raises £550k in funding led by SFC Capital for early dementia detection platform
EquityHealth - 14 May 2026

EarswitchEarswitch raises funding led by PXN Ventures for in-ear blood pressure and vital sign monitoring
EquityHealth
